Status:
COMPLETED
Associations of Age Measures With Serum Anti-Müllerian Hormone
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Aging
Eligibility:
FEMALE
35-45 years
Brief Summary
This study aims to assess the association between aging and serum anti-müllerian hormone.
Detailed Description
As life expectancy is increasing and has significant effects on health, economy and other aspects, the need for an Active and Healthy ageing (AHA) strategy becomes more important. Although ageing is o...
Eligibility Criteria
Inclusion
- Informed consent as documented by signature
- Female
- Age between 35 and 45 years
- German as native language
- Regular menstrual cycle with a mean length of 21-35 days
- Next menstrual period is predictable within a 7-day time frame
- Willing to attend bio-functional status analysis and to give blood and saliva samples
Exclusion
- Pregnancy or breastfeeding
- Hormonal contraception
- Chronic diseases
- Mental illness
- Smoking \>10 cigarettes per day or over 10 packyears
- Consumption of \>30g alcohol per day (\>1 liter of beer or \>0.3 liter of wine)
- Inability to give consent
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 20 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05297058
Start Date
July 1 2022
End Date
March 20 2024
Last Update
October 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Obstetrics and Gynecology, Bern University Hospital
Bern, Switzerland